Senate moves to wrap up opioid bill
© Greg Nash
The Senate is hoping to finish its work on a bipartisan opioid bill next week. 
 
Majority Leader Mitch McConnellMitch McConnellRepublicans play clean up on Trump's foreign policy Americans brimming with optimism on the economy McCain hopes Americans can be confident GOP-controlled Congress can investigate president MORE (R-Ky.) moved to end debate on the Comprehensive Addiction and Recovery Act (CARA) and a key substitute amendment on Thursday evening. 
 
ADVERTISEMENT
Senators will take a first procedural vote Monday at 5:30 p.m., with 60 votes needed to overcome the hurdle. 
 
Minority Leader Harry ReidHarry ReidIf Gorsuch pick leads to 'crisis,' Dems should look in mirror first Senate confirms Mulvaney to be Trump’s budget chief Democrats declare victory after Puzder bows out MORE (D-Nev.) suggested earlier that Democrats could block the legislation over an amendment fight, but walked that back on Thursday evening. 
 
"We're not holding up this bill," he said. "We're not going to oppose cloture." 
 
The move comes after a brief back-and-forth between McConnell and Reid, with both senators wanting to set up additional amendment votes. 
 
 
The Nevada Democrat has been pushing for a "robust amendment process." He said it wasn't "appropriate" that one of the amendments the Kentucky Republican was trying to schedule for a vote was from a senator facing a tough reelection bid. 
 
McConnell objected and instead tried to bring up 10 amendments, including four from Democrats. 
 
Reid, however, blocked his request, saying, "It's not right to have the majority pick the votes of the minority." 
 
The amendment scuffle comes after Republicans suggested that Democrats were slow walking the opioid bill because of a separate fight over the Supreme Court. 
 
 
Despite the floor battles the legislation — from Sens. Rob Portman (R-Ohio) and Sen. Sheldon Whitehouse (D-R.I.) — has bipartisan support. It authorizes funding for programs to combat prescription drug and heroin abuse, in addition to increasing the availability of naloxone, a drug to treat overdose.